What To Expect When NVIDIA (NVDA) Releases Q3 Earnings

NVIDIA is set to report fiscal Q3 after the close amid lofty expectations following a record Q2 ($46.7bn) driven by Blackwell, with consensus Q3 revenue of $55.09bn and normalized EPS $1.26 (implying ~57% revenue and 55% EPS YoY growth) and full-year 2026 estimates of $207.95bn revenue and $4.57 EPS. Management said Blackwell reached record levels and GB300 production is running at roughly 1,000 racks per week, networking revenue hit $7.3bn, and Rubin platform chips (Vera CPU, Rubin GPU, CX9 SuperNIC) are in fab for a volume launch next year—factors that reinforce NVIDIA’s central role in a multi‑trillion-dollar AI infrastructure build-out that Jensen Huang pegs at $3–4tn (hyperscaler CapEx ~ $600bn/year). Key catalysts to watch in the print and guidance are the pace of GB300 capacity scaling, continued networking growth, any update on H20 licensing to China (management excluded H20 from the Q3 outlook but noted $2–5bn of potential revenue if approved), and supply-chain/readiness commentary on Rubin.

Analysis

NVIDIA is due to report fiscal Q3 after the close with consensus revenue of $55.09 billion and normalized EPS of $1.26, implying roughly 57% revenue and 55% EPS year‑over‑year growth versus Q3 FY2025 comparatives of $35.08 billion and $0.81 respectively; full‑year 2026 estimates sit at $207.95 billion revenue and $4.57 EPS, reflecting the market’s expectation that recent momentum continues after a Q2 print of $46.7 billion. Management highlighted Blackwell strength and said GB300 production is "running at roughly 1,000 racks per week," while networking revenue was a record $7.3 billion last quarter; Rubin platform components are in fab and targeted for volume next year, underscoring a platform-level compute, networking and software strategy. Key near-term catalysts are the cadence of GB300/GB300 capacity scaling, any acceleration of CSP deployments, networking growth (NVLink/InfiniBand/Spectrum‑X) and clarity on H20 China licensing — management excluded H20 from the Q3 outlook but estimated $2–5 billion of potential revenue if approvals come through. Upside is tied to continued Blackwell/Rubin ramps and hyperscaler CapEx (management cited ~$600 billion/year now), while downside hinges on China export approvals, supply‑chain readiness and capacity or power constraints at multi‑gigawatt AI sites.

Key Decisions for Investors

• Positioning: maintain exposure to NVDA for strategic AI infrastructure exposure but size positions given execution and geopolitical binary risks,
• Event monitoring: treat management commentary on GB300 racks/week, networking growth trends, H20 licensing status for China, and Rubin volume timing as primary trading triggers to add or trim exposure,
• Risk management: use tactical hedges (options or collars) around the print and initial reaction to limit downside from an adverse China/licensing update or supply‑chain delay